Ruben Mesa, M.D., Chair of Hematology and Oncology at Mayo Clinic in Arizona, discusses common patient questions regarding myeloproliferative neoplasms with John Camoriano, M.D., medical oncology consultant at Mayo Clinic.Read more about Answering Common Patient Questions on Myeloproliferative Neoplasms – Mayo Clinic
Ruben Mesa, M.D. and Veena Fauble, M.D., Mayo Clinic hematologists, discuss bone marrow transplant as a treatment option for patients diagnosed with myelofibrosis.Read more about Myelofibrosis and Bone Marrow Transplant – Mayo Clinic
Ruben Mesa, M.D., hematologist and Deputy Director of the Mayo Clinic Cancer Center in Arizona, provides his top ten recommendations for battling the fatigue associated with a diagnosis of myeloproliferative neoplasm.Read more about Top 10 Tips for Battling the Fatigue Associated with Myeloproliferative Neoplasms – Mayo Clinic
“Living well with blood disorders”.Read more about Dr. John Camoriano, Mayo Clinic Scottsdale AZ
“Ruben Mesa, M.D., hematologist at Mayo Clinic in Arizona, discusses MPD-RC 112, a randomized trial of pegylated interferon alfa-2a versus hydroxyurea therapy in the treatment of high risk polycythemia vera (PV) and high risk essential thrombocythemia (ET).”Read more about MPD-RC 112 Clinical Trial for High Risk Polycythemia Vera and Essential Thrombocythemia
What tests are important for an MPN patient as they go on their journey? MPN Expert, Dr. Srdan Verstovsek, explains.Read more about What is an MPN?
Advances in treatment for MDS/MPN are not keeping pace with the rapid improvement in understanding of the genetics of these diseases. Too little is known about how to treat these patients.Read more about Suffering from an Identity Crisis: Medications and Measures of Treatment Response in MDS/MPN.
Diagnosis of MDS or MDS/MPN must begin with morphology (analysis of the form and structure of patient blood or bone marrow cells). When used alone, today’s advanced techniques to study genes and chromosomes don’t give enough information to find out what type of MDS or MDS/MPN a patient has.Read more about Drivers or Passengers? Genetics of MDS and MDS/MPN
Conventional cytogenetics is a method to analyze chromosomes. Researchers and clinicians use conventional cytogenetics to diagnose blood disorders, predict outcomes in patients with these disorders, and develop new treatments that target genetic changes associated with a disease.Read more about There is Always Room for Improvement: Changing Role of Chromosome Analysis in MDS and MDS/MPN.